Form 4: Arteris Inc. Director Sells Shares Under 10b5-1 Plan

Arteris, Inc. Director Antonio J. Viana reported a sale of 20,000 shares of common stock under a pre-arranged 10b5-1 trading plan.

Summary

• Director Antonio J. Viana of Arteris, Inc. has reported a transaction involving the sale of 20,000 shares of common stock.
• The sale occurred on April 17, 2026, and was executed under a Rule 10b5-1 trading plan adopted on June 10, 2025.
• The weighted average sale price for these shares was $22.1084, with individual sales ranging from $22.00 to $22.24.
• Following this transaction, Viana beneficially owns 144,620 shares of common stock, held indirectly through the Viana Family Trust.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing neutrally. While a director selling shares can be a negative signal, the transaction was conducted under a pre-established 10b5-1 plan, mitigating concerns about insider trading and suggesting a pre-determined divestment strategy.

Negatives

• Director Antonio J. Viana sold a significant number of shares (20,000) which could be perceived negatively by the market, although it was executed under a pre-planned 10b5-1 trading plan.

Risks

• The sale of shares by a director, even under a 10b5-1 plan, could be interpreted by the market as a lack of confidence in the company's future prospects, potentially impacting share price.

Future Outlook

No specific future outlook or guidance is provided in this Form 4 filing, which solely reports a change in beneficial ownership.

Industry Context

StockSavvy.ai notes that Form 4 filings reporting insider transactions are common and provide transparency into executive and director stock dealings. The use of a 10b5-1 plan is a standard mechanism for insiders to sell shares without triggering insider trading concerns, provided the plan is established when the insider does not possess material non-public information.

Stakeholder Impact

• Shareholders: May view the director's sale with caution, although the 10b5-1 plan provides a degree of reassurance against negative insider trading perceptions.

Next Steps

• The reporting person will continue to hold the remaining 144,620 shares beneficially owned through the Viana Family Trust.

Key Dates

Keywords

Arteris Inc., Form 4, SEC Filing, Director Sale, 10b5-1 Plan, Common Stock, Beneficial Ownership, Insider Trading